Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Computed tomography (CT) and Priority Driven positron emission tomography Collaborative Cancer University of (PET)/CT surveillance imaging The University of Cancer $481,698.00 08/03/2017 36 2006 Australia Sydney in asymptomatic Stage III Sydney Research melanoma patients - a Scheme prospective cohort study of clinical benefit and economic implications: ID1129568. Ref: CA-G1516/57 Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reversing Priority Driven glucocorticoid resistance in Collaborative Lowy Cancer Cancer paediatric acute Cancer Research Centre, $296,428.50 10/03/2017 36 Kensington 2052 Australia lymphoblastic leukaemia - a Research University of NSW novel epigenetic mechanism Scheme linked to lymphocyte-specific chromatin conformation: ID1129129. Ref: CA-G1516/52 Priority Driven Collaborative Cancer Research Scheme Priority Driven (PDCCRS) 2016: ASCOLT: Collaborative Aspirin for Dukes C and High Cancer University of The University of Cancer Risk Dukes B Colorectal $213,459.53 17/03/2017 36 2006 Australia Sydney Sydney Research Cancers. An International, Scheme Multi-centre, Double Blind, Randomised Trial: ID1122632 Ref: CA-G1516/51 Priority Driven Collaborative Priority Driven Cancer Research Scheme Collaborative Lowy Cancer (PDCCRS) 2016: Targeting Cancer Cancer Research Centre, FACT to inhibit MYCN-driven $496,055.50 17/03/2017 36 Kensington 2052 Australia Research University of NSW transcription in Scheme neuroblastoma: ID1123235 Ref: CA-G1516/53 Priority Driven Collaborative Priority Driven Cancer Research Scheme Council of the Collaborative (PDCCRS) 2016: Improving Cancer Queensland Cancer Natural Killer cell responses to $49,669.50 17/03/2017 12 Herston 4006 Australia Institute of Medical Research immunotherapy in Research Scheme haematological cancers: ID1122183. Ref: CA-G1516/59 Priority Driven Priority Driven Collaborative Sydney Children's Cancer Collaborative Cancer Research Scheme Hospital, University $200,000.00 23/03/2017 36 Kensington 2052 Australia Cancer (PDCCRS) 2016: Synthetic of NSW Research retinoid therapy for Diffuse
Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Computed tomography (CT) and positron emission tomography (PET)/CT surveillance imaging in asymptomatic Stage III melanoma patients - a prospective cohort study of clinical benefit and economic implications: ID1129568. Ref: CA-G1516/57 $481,698.00 08/03/2017 36 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Lowy Cancer Research Centre, University of NSW Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia - a novel epigenetic mechanism linked to lymphocyte-specific chromatin conformation: ID1129129. Ref: CA-G1516/52 $296,428.50 10/03/2017 36 Kensington 2052 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Sydney Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial: ID1122632 Ref: CA-G1516/51 $213,459.53 17/03/2017 36 The University of Sydney 2006 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Lowy Cancer Research Centre, University of NSW Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma: ID1123235 Ref: CA-G1516/53 $496,055.50 17/03/2017 36 Kensington 2052 Cancer Australia Priority Driven Collaborative Cancer Research Scheme Council of the Queensland Institute of Medical Research Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Improving Natural Killer cell responses to immunotherapy in haematological cancers: ID1122183. Ref: CA-G1516/59 $49,669.50 17/03/2017 12 Herston 4006 Cancer Australia Priority Driven Collaborative Cancer Research Sydney Children's Hospital, University of NSW Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2016: Synthetic retinoid therapy for Diffuse $200,000.00 23/03/2017 36 Kensington 2052
grants_reporting_20170703.docx